53 related articles for article (PubMed ID: 31046849)
1. Decrease in vancomycin-resistant Enterococcus colonization associated with a reduction in carbapenem use as empiric therapy for febrile neutropenia in patients with acute leukemia.
Ford CD; Coombs J; Stofer MG; Lopansri BK; Webb BJ; Ostronoff F; Asch J; Hoda D
Infect Control Hosp Epidemiol; 2019 Jul; 40(7):774-779. PubMed ID: 31046849
[TBL] [Abstract][Full Text] [Related]
2. Vancomycin-resistant enterococci colonization in patients with hematological malignancies: screening and its cost-effectiveness.
Gedik H; Şimşek F; Kantürk A; Yıldırmak T; Arıca D; Aydın D; Yokuş O; Demirel N
Afr Health Sci; 2014 Dec; 14(4):899-905. PubMed ID: 25834499
[TBL] [Abstract][Full Text] [Related]
3. The outcome of non-carbapenem-based empirical antibacterial therapy and VRE colonisation in patients with hematological malignancies.
Gedik H; Yildirmak T; Simsek F; Kanturk A; Aydýn D; Anca D; Yokus O; Demirel N
Afr Health Sci; 2013 Jun; 13(2):362-8. PubMed ID: 24235937
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of vancomycin resistant Enterococci and associated risk factors among clients with and without HIV in Northwest Ethiopia: a cross-sectional study.
Abebe W; Endris M; Tiruneh M; Moges F
BMC Public Health; 2014 Feb; 14():185. PubMed ID: 24555580
[TBL] [Abstract][Full Text] [Related]
5. Feasibility, efficacy, and adverse effects of outpatient antibacterial prophylaxis in children with acute myeloid leukemia.
Inaba H; Gaur AH; Cao X; Flynn PM; Pounds SB; Avutu V; Marszal LN; Howard SC; Pui CH; Ribeiro RC; Hayden RT; Rubnitz JE
Cancer; 2014 Jul; 120(13):1985-92. PubMed ID: 24677028
[TBL] [Abstract][Full Text] [Related]
6. Bloodstream infections in neutropenic cancer patients: A practical update.
Gustinetti G; Mikulska M
Virulence; 2016 Apr; 7(3):280-97. PubMed ID: 27002635
[TBL] [Abstract][Full Text] [Related]
7. Uropathogenic distribution and antibiotic resistance patterns according to multidrug-resistant bacteria colonization status in patients with stroke.
Kim JH; Lee JH; Sim YJ; Kim GC; Jeong HJ
Medicine (Baltimore); 2024 Jan; 103(4):e36980. PubMed ID: 38277567
[TBL] [Abstract][Full Text] [Related]
8. Low utilization of vancomycin in febrile neutropenia: real-world evidence from 4 Brazilian centers.
Ramos JF; Pereira AD; Seiwald MCN; Gandolpho LS; Molla VC; Guaraná M; Nouér SA; Nucci M; Rodrigues CA
Support Care Cancer; 2023 Nov; 31(12):687. PubMed ID: 37947888
[TBL] [Abstract][Full Text] [Related]
9. Analysis of bacteremia at first-line antibiotic treatment for febrile neutropenia in children and adolescents: A retrospective, single-center analysis.
Kobayashi R; Sano H; Matsushima S; Hori D; Yanagi M; Suzuki D
J Infect Chemother; 2024 Jul; 30(7):642-645. PubMed ID: 38301745
[TBL] [Abstract][Full Text] [Related]
10. Febrile neutropenia management and outcomes in hematopoietic cell transplantation for chronic granulomatous disease.
Parta M; Cuellar-Rodriguez J; Gea-Banacloche J; Qin J; Kelly C; Zerbe CS; Holland SM; Malech HL; Kang EM
Transpl Infect Dis; 2022 Apr; 24(2):e13815. PubMed ID: 35191140
[TBL] [Abstract][Full Text] [Related]
11. Empiric treatment of healthcare-associated central nervous system infections in Denmark: do we need carbapenems?
Kraef C; Hertz FB; Riis Olesen B; Sigurdsson ST; Bergdal OK; Gitz Holler J; Mens H; Helweg-Larsen J; Andersen ÅB; Møller K; Knudsen JD
Infect Dis (Lond); 2024 May; 56(5):402-409. PubMed ID: 38339990
[TBL] [Abstract][Full Text] [Related]
12. Application of the Weighted-Incidence Syndromic Combination Antibiogram (WISCA) to guide the empiric antibiotic treatment of febrile neutropenia in oncological paediatric patients: experience from two paediatric hospitals in Northern Italy.
Liberati C; Donà D; Maestri L; Petris MG; Barbieri E; Gallo E; Gallocchio J; Pierobon M; Calore E; Zin A; Brigadoi G; Mariani M; Mesini A; Saffioti C; Ugolotti E; Gregori D; Giaquinto C; Castagnola E; Biffi A
Ann Clin Microbiol Antimicrob; 2024 Feb; 23(1):16. PubMed ID: 38360651
[TBL] [Abstract][Full Text] [Related]
13. Screening for multidrug-resistant organisms in high-risk hospitalized patients with hematologic diseases.
Delanote V; Callens R; Vogelaers D; Deeren D
Eur J Haematol; 2024 Apr; 112(4):627-632. PubMed ID: 38122813
[TBL] [Abstract][Full Text] [Related]
14. Which Multidrug-Resitant Bacteria are Emerging in Patients with Hematological Malignancies?: One-Year Report.
Gedik H; Şimşek F; Yıldırmak T; Kantürk A; Aydın D; Demirel N; Yokuş O; Arıca D
Indian J Hematol Blood Transfus; 2015 Mar; 31(1):51-6. PubMed ID: 25548445
[TBL] [Abstract][Full Text] [Related]
15. Individualized Antibiotic Plans as a Quality Improvement Initiative to Reduce Carbapenem Use for Hematopoietic Cell Transplant Patients at a Freestanding Pediatric Hospital.
Brothers AW; Pak DJ; Poole NM; Kronman MP; Bettinger B; Wilkes JJ; Carpenter PA; Englund JA; Weissman SJ
Clin Infect Dis; 2024 Jan; 78(1):15-23. PubMed ID: 37647637
[TBL] [Abstract][Full Text] [Related]
16. FOVOCIP study: a multicenter randomized trial of fosfomycin versus ciprofloxacin for febrile neutropenia in hematologic patients-efficacy and microbiologic safety.
Moreno AF; Lavín-Alconero L; de Ugarriza PL; Blanco LS; Hernández SC; Burgués JMB; de Miguel MI; Huerta AJG; Zarzuela MP; Boluda B; Humala K; Calabuig ML; Amigo ML; Casas MC; Del Mar García-Saiz M; Verdugo AF; Domínguez JF; Bernal T
Trials; 2023 Oct; 24(1):694. PubMed ID: 37891616
[TBL] [Abstract][Full Text] [Related]
17. Gut Microbiome Signatures Are Predictive of Infectious Risk Following Induction Therapy for Acute Myeloid Leukemia.
Galloway-Peña JR; Shi Y; Peterson CB; Sahasrabhojane P; Gopalakrishnan V; Brumlow CE; Daver NG; Alfayez M; Boddu PC; Khan MAW; Wargo JA; Do KA; Jenq RR; Kontoyiannis DP; Shelburne SA
Clin Infect Dis; 2020 Jun; 71(1):63-71. PubMed ID: 31436833
[TBL] [Abstract][Full Text] [Related]
18. Molecular Rapid Diagnostics Improve Time to Effective Therapy and Survival in Patients with Vancomycin-Resistant
Bandy SM; Jackson CB; Black CA; Godinez W; Gawrys GW; Lee GC
Antibiotics (Basel); 2023 Jan; 12(2):. PubMed ID: 36830121
[TBL] [Abstract][Full Text] [Related]
19. Management of febrile neutropenia in a patient with acute leukemia.
Bryant AL; Walton A; Albrecht TA
J Emerg Nurs; 2014 Jul; 40(4):377-81. PubMed ID: 24054730
[TBL] [Abstract][Full Text] [Related]
20. Elevated plasma phage load as a marker for intestinal permeability in leukemic patients.
Yin XR; Liu P; Xu X; Xia Y; Huang KZ; Wang QD; Lai MM; Yu QG; Zheng XQ
Med Microbiol Immunol; 2020 Dec; 209(6):693-703. PubMed ID: 32995957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
